X   

Real-Time Quote

Enter Company or MF
   

Polar Pharma India Ltd. - Research Center

523333  POLARPH  Group (S) BSE data View Tips   Add to :  Portfolio  |  Watchlist  |  Game

(Rs crore)

Balance sheet

 Mar ' 09Mar ' 08Mar ' 07Mar ' 06Mar ' 05

Sources of funds

Owner's fund
Equity share capital 12.27 12.27 12.27 12.27 11.97
Share application money-----
Preference share capital 1.25 1.25 1.25 1.25 1.25
Reserves & surplus -79.21 -11.28 -8.74 -0.75 -7.98

Loan funds

Secured loans 84.14 41.28 43.86 36.74 55.50
Unsecured loans 0.54 0.40 1.02 2.84 0.19
Total 18.98 43.92 49.65 52.35 60.93

Uses of funds

Fixed assets
Gross block 52.11 53.64 53.83 54.03 52.32
Less : revaluation reserve-----
Less : accumulated depreciation 25.97 24.78 22.73 20.17 17.50
Net block 26.13 28.86 31.10 33.86 34.82
Capital work-in-progress--- 0.02 0.27
Investments-----

Net current assets

Current assets, loans & advances 6.04 24.55 37.11 33.94 52.05
Less : current liabilities & provisions 13.19 9.50 18.57 15.88 27.09
Total net current assets -7.16 15.06 18.54 18.06 24.96
Miscellaneous expenses not written--- 0.41 0.88
Total 18.98 43.92 49.65 52.35 60.93

Notes:

Book value of unquoted investments-----
Market value of quoted investments-----
Contingent liabilities 0.18 0.15 0.17 0.15 1.66
Number of equity sharesoutstanding (Lacs) 122.71 122.71 122.71 122.71 119.71